Takenobu Katagiri - Search Results

Year	Number of Results
2002	3
2003	1
2005	4
2006	8
2007	4
2008	7
2009	6
2010	7
2011	6
2012	10
2013	4
2014	5
2015	4
2016	3
2017	2
2018	6
2019	1
2020	6
2021	3
2022	1
2023	4
2024	1

1

Katagiri T, Watabe T. Katagiri T, et al. Cold Spring Harb Perspect Biol. 2016 Jun 1;8(6):a021899. doi: 10.1101/cshperspect.a021899. Cold Spring Harb Perspect Biol. 2016. PMID: 27252362 Free PMC article. Review.

2

Recent Topics in Fibrodysplasia Ossificans Progressiva.

Katagiri T, Tsukamoto S, Nakachi Y, Kuratani M. Katagiri T, et al. Endocrinol Metab (Seoul). 2018 Sep;33(3):331-338. doi: 10.3803/EnM.2018.33.3.331. Endocrinol Metab (Seoul). 2018. PMID: 30229572 Free PMC article. Review.

3

A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders.

Katagiri T, Tsukamoto S, Kuratani M, Tsuji S, Nakamura K, Ohte S, Kawaguchi Y, Takaishi K. Katagiri T, et al. Nat Commun. 2023 May 25;14(1):2960. doi: 10.1038/s41467-023-38746-5. Nat Commun. 2023. PMID: 37231012 Free PMC article.

4

Fibrodysplasia ossificans progressiva: Review and research activities in Japan.

Haga N, Nakashima Y, Kitoh H, Kamizono J, Katagiri T, Saijo H, Tsukamoto S, Shinoda Y, Sawada R, Nakahara Y. Haga N, et al. Among authors: katagiri t. Pediatr Int. 2020 Jan;62(1):3-13. doi: 10.1111/ped.14065. Pediatr Int. 2020. PMID: 31774601 Review.

5

Wnt7b expressed by hypertrophic chondrocytes is a stimulatory factor for endochondral ossification that is regulated by Smad4 activity.

Tsukamoto S, Kuratani M, Tanaka S, Jimi E, Oda H, Katagiri T. Tsukamoto S, et al. Among authors: katagiri t. Development. 2023 Aug 1;150(15):dev201734. doi: 10.1242/dev.201734. Epub 2023 Aug 4. Development. 2023. PMID: 37539462

6

Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily.

Katagiri T, Tsukamoto S, Nakachi Y, Kuratani M. Katagiri T, et al. Int J Mol Sci. 2018 Nov 13;19(11):3586. doi: 10.3390/ijms19113586. Int J Mol Sci. 2018. PMID: 30428615 Free PMC article. Review.

7

Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva.

Katagiri T, Tsukamoto S, Kuratani M. Katagiri T, et al. Bone. 2018 Apr;109:241-250. doi: 10.1016/j.bone.2017.07.024. Epub 2017 Jul 25. Bone. 2018. PMID: 28754575 Free article. Review.

8

Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP).

Kaplan FS, Shen Q, Lounev V, Seemann P, Groppe J, Katagiri T, Pignolo RJ, Shore EM. Kaplan FS, et al. Among authors: katagiri t. J Bone Miner Metab. 2008;26(6):521-30. doi: 10.1007/s00774-008-0879-8. Epub 2008 Nov 1. J Bone Miner Metab. 2008. PMID: 18979151 Free PMC article. Review.

9

Critical Roles of NF-κB Signaling Molecules in Bone Metabolism Revealed by Genetic Mutations in Osteopetrosis.

Jimi E, Katagiri T. Jimi E, et al. Among authors: katagiri t. Int J Mol Sci. 2022 Jul 20;23(14):7995. doi: 10.3390/ijms23147995. Int J Mol Sci. 2022. PMID: 35887342 Free PMC article. Review.

10

Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders.

Katagiri T, Tsukamoto S, Kuratani M. Katagiri T, et al. Biomedicines. 2021 Jun 26;9(7):736. doi: 10.3390/biomedicines9070736. Biomedicines. 2021. PMID: 34206903 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year